On July 13, 2017, Chuck Olson tendered his letter of resignation from the role of Senior Vice President, Chief Technology Officer of Anthera Pharmaceuticals, Inc., effective July 13, 2017. Dr. Olson will continue to be available to the company in an advisory role with respect to the company's manufacturing strategy. On July 13, 2017, Dr. Renee Martin, Ph.D., who joined Anthera Pharmaceuticals, Inc. in March 2010 and is currently serving as the company's Senior Vice President, Medical Science, will assume functional leadership for the company's manufacturing strategy which complements and expands her background of scientific research.